生长抑素受体配体荧光成像识别脑膜瘤细胞的体外研究
所有脑膜瘤细胞培养均见荧光(22例强染色、2例中等),不同WHO级别间信号质与量无差异,硬脑膜细胞未染色。结论提示FAM-TOC可用于体外选择性荧光识别脑膜瘤细胞,尚需动物模型进一步在体验证。
要点
- FAM-TOC孵育后所有脑膜瘤细胞培养均见荧光,硬脑膜细胞未染色。
- 不同WHO级别脑膜瘤间荧光信号质与量无差异,信号持续至4小时不变。
- 结果仅为体外实验,作者提出下一步需动物模型进行在体验证。
核心结论
- 本研究证明FAM-TOC可在体外选择性荧光识别脑膜瘤细胞。
- 作者认为需进一步评估所用生长抑素受体配体与荧光染料的化学动力学,并需动物模型在体验证这些初步结果。
研究设计与样本
- 孵育后在三个不同时间点用488 nm落射荧光显微镜分析所有细胞培养的荧光信号与强度。
主要发现
- 所有脑膜瘤细胞培养均检出荧光:22例强染色、2例中等,孵育后即刻至4小时后均可见。
- 不同脑膜瘤级别间荧光信号的质量与数量无差异,分析期间荧光信号保持不变。
- 阴性对照中硬脑膜细胞培养未染色。
临床怎么用
- 作者提出FAM-TOC有望用于脑膜瘤细胞的体外选择性荧光识别,尤其针对需术中荧光识别的侵袭性颅底脑膜瘤。
- 作者明确下一步需动物模型评估这些初步结果的在体适用性。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of five-aminolevulinic acid (5-ALA) in the staining of malignant glioma cells has significantly improved intraoperative radicality in the resection of gliomas in the last decade. Currently, there is no comparable selective fluorescent substance available for meningiomas. There is however a demand for intraoperative fluorescent identification of, e.g., invasive skull base meningiomas to help improve safe radical resection. Meningiomas show high expression of the somatostatin receptor type 2, offering the possibility of receptor-targeted imaging. The authors used a somatostatin receptor-labeled fluorescence dye in the identification of meningiomas in vitro. The aim of this study was to evaluate the possibility of selective identification of meningioma cells with fluorescent techniques. METHODS: Twenty-four primary human meningioma cell cultures were analyzed. The tumor cells were incubated with FAM-TOC (5,6-Carboxyfluoresceine-Tyr3-Octreotide). As a negative control, four human dura tissues were cultured as well as a mixed cell culture in vitro and incubated with the same somatostatin receptor-labeled fluorescence substance. After incubation, fluorescence signal and intensity in all cell cultures were analyzed at three different time points using a fluorescence microscope with 488 nm epi-illumination. RESULTS: Sixteen WHO I, six WHO II, two WHO III meningioma primary cell cultures, and four dura cell cultures were analyzed. Fluorescence was detected in all meningioma cell cultures (22 cell culture stained strongly, 2 cell cultures moderately) directly after incubation up until 4 h later. There were no differences in the quality and quantity of fluorescence signal between the various meningioma grades. The fluorescence signal persisted unchanged during the analyzed period. In the negative control, dura cell cultures remained unstained. CONCLUSIONS: This study demonstrates the use of FAM-TOC in the selective fluorescent identification of meningioma cells in vitro. Further evaluation of the chemical kinetics of the applied somatostatin receptor ligand and fluorescence dye is warranted. As a next step, an experimental animal model is needed to evaluate these promising results in vivo.
引用
- Linsler S, Ketter R, Oertel J, et al. Fluorescence imaging of meningioma cells with somatostatin receptor ligands: an in vitro study. Acta Neurochir (Wien). 2019. PMID: 30877475. doi:10.1007/s00701-019-03872-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。